Efficacy and safety of luseogliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: a 12-week,randomized, placebo-controlled,phase II study
1. Kansai Electric Power Hospital
OsakaJapan;2. Jikei University School of Medicine
TokyoJapan;3. Yachiyo Hospital
AichiJapan;4. Taisho Pharmaceutical Co. Ltd
TokyoJapan